High Rate of Drug-Free Remission After Induction Therapy With Golimumab in Early Peripheral Spondyloarthritis
Author:
Affiliation:
1. Ghent University Hospital and VIB Inflammation Research Center; Ghent University; Ghent Belgium
2. Biostatistics Unit of the Faculty of Medicine and Health Sciences; Ghent University; Ghent Belgium
Funder
Janssen Pharmaceuticals
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.40573/fullpdf
Reference38 articles.
1. The assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general;Rudwaleit;Ann Rheum Dis,2011
2. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis;Braun;Ann Rheum Dis,2011
3. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT);Van der Heijde;Arthritis Rheum,2005
4. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial;Davis;Arthritis Rheum,2003
5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial;Van der Heijde;Arthritis Rheum,2006
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question;Best Practice & Research Clinical Rheumatology;2023-09
2. Potential for sustaining remission in ankylosing spondylitis patients upon netakimab discontinuation;Meditsinskiy sovet = Medical Council;2023-07-24
3. Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial;Rheumatology;2022-10-06
4. Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA;Therapeutic Advances in Musculoskeletal Disease;2022-01
5. The Value of Magnetic Resonance Imaging for Assessing Disease Extent and Prediction of Relapse in Early Peripheral Spondyloarthritis;Arthritis & Rheumatology;2021-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3